WELCOME TO EU-OPENSCREEN
A European Infrastructure of Screening Platforms
EU-OPENSCREEN, the European Infrastructure of Open Screening Platforms for Chemical Biology, integrates high-throughput screening platforms, chemical libraries, chemical resources for hit discovery and optimisation, bio- and cheminformatics support, and a database containing screening results, assay protocols, and chemical information.
These platforms - offering the most advanced technologies - will be used by European researchers from academia and SMEs in order to identify compounds affecting new targets. Open access to an integrated infrastructure for Chemical Biology will thus satisfy the needs for new bioactive compounds in many fields of the Life Sciences (e.g. human and veterinary medicine, systems biology, biotechnology, agriculture and nutrition).
Spain signed as 10th country the EU-OPENSCREEN MoU
Now ten countries (Czech Republic, Finland, France, Germany, Greece, Hungary, Norway , Poland, Romania, Spain) and one international organisation (EMBL) have signed EU-OPENSCREEN's Memorandum of Understanding (MoU) and participate in EU-OPENSCREEN's Transition Committee dedicated to take all necessary steps towards the implementation of the European research infrastructure.
Paper on Design of the European Compound Screening Library now published
This paper describes a collaborative effort to define and apply a protocol for the rational selection of a general-purpose screening library, to be used by the screening platforms affiliated with the EU-OPENSCREEN initiative.
See here for more Information.
6th EU-OPENSCREEN General Assembly Meeting in Heidelberg
The 6th EU-OPENSCREEN General Assembly Meeting will be held on August 20 directly before the EMBO Conference "Chemical Biology 2014" in Heidelberg at the EMBL Advanced Training Center. The consortium members of the preparatory phase will debate the latest results from the workpackages and the progress of the Transition Committee on the establishment of the EU-OPENSCREEN ERIC. The members will further discuss the participation of EU-OPENSCREEN in Horizon2020 calls and in other European and global initiatives and programs.
Memorandum of Understanding with Australian Research Institutions signed
On May 16 2014 a Memorandum of Understanding between EU-OPENSCREEN, Compounds Australia and Therapeutics Innovations Australia was signed in the frame of the EU-Australia Workshops on "Healthy Aging: Global Research Infrastructure Consortia". By bringing together Australian and European researchers, and drawing on our collective research strengths in chemistry and biology, this project points the way to the future of global health research. The ceremony was hosted by the Australian Embassador in Brussels and accompanied by the head of the research infrastructures unit of the European Comission Ana Arana-Antelo.
From left to right: Ana Arana-Antelo, EU Comission DG RTD HoU B.4 Research Infrastructures; Prof. Ronald Quinn, Director of the Eskitis Institut; Stewart Hay, Therapeutic Innovation Australia; Ambassador Lewis Duncan, Australian Embassy and Mission to the EU; Dr. Ronald Frank, Leibniz-Institut für Molekulare Pharmakologie, EU-OPENSCREEN Coordinator.
Memorandum of Understanding with nine European countries entered into force
Nine countries (Czech Republic, Finland, France, Germany, Greece, Hungary, Norway, Poland and Romania) and one international organisation (EMBL) are signing EU-OPENSCREEN's Memorandum of Understanding (MoU). The Signatories participate in EU-OPENSCREEN's Transition Committee and will make a dedicated effort to take all necessary steps towards the implementation of the European research infrastructure. Additional partner countries, where negotiations to sign the MoU are on-going, are invited to join the Transition Committee at a later stage.
Position paper on data management and sharing
The EU-funded project BioMedBridges, of which EU-OPENSCREEN is a partner, developed a position paper on the principles of data management and sharing at European Research Infrastructures, which can be downloaded here.
Cambridge Healthtech Institute is proud to announce the Inaugural Chemical Biology for Target Validation conference, established to convene an interdisciplinary collection of leaders in chemical/structural biology, chemical proteomics, medicinal chemistry, synthetic chemistry and chemogenomics to discuss strategies to de-risk novel discovery initiatives. May 22-23, 2014. Westin Boston Waterfront, Boston, MA
EU-OPENSCREEN's 5th Project and 3rd Stakeholder Meeting took place in Oslo, November 19-20, 2013.
See here for the agenda and further information.
Opening of new CZ-OPENSCREEN infrastructure facility in Prague
The Czech Minister for Education Youth and Sports Dr. Dalibor Štys (left), EU-OPENSCREEN coordinator Dr. Ronald Frank (middle), and director of Institute for Molecular Genetics of the Czech Academy of Sciences (IMG) Prof. Dr. Václav Hořejší are cutting the ribbon for the official opening of the new CZ-OPENSCREEN infrastructure facility in Prague on 24th September 2013. (http://www.openscreen.cz/)
To the right: Head of Cell Differentiation Laboratory at IMG and coordinator of CZ-OPENSCREEN. Dr. Petr Bartůněk, head of the new facility. Please click images to enlarge.
When Chemical Biology meets Drug Design
This major international symposium gathered more than 600 scientists from around the world at the Conference Center Nice Acropolis. EU-OPENSCREEN was also presenting at this conference in Nice.
WIRE 2013: Máire Geoghegan-Quinn, commissioner for research, innovation and science, visited the EU-OPENSCREEN poster at the Week of Innovative Regions in Europe (WIRE) Conference in Cork.
EU-OPENSCREEN at IRDiRC 2013: Stakeholders active in the rare disease area from across the globe convened in Dublin at the First International Rare Diseases Research Consortium (IRDiRC) Conference.
A report can be downloaded here.
German Roadmap for large research infrastructures: Based on the evaluation report from the German Council of Science and Humanities (Wissenschaftsrat), the German Federal Ministry of Education and Research (BMBF) included EU-OPENSCREEN in its new Roadmap.
Our new slogan is Chemical Keys for Life's Locks, as announced at the Mid-term Review Meeting in Vienna, in July 2012.
The Preparatory Phase Project receives funding from the
European Union Seventh Framework Programme (FP7/2007-2013)
under grant agreement n° 261861.